https://news.medxy.ai/reevaluating-sentinel-lymph-node-biopsy-in-older-women-with-ct2n0-hr-her2-breast-cancer-limited-impact-on-treatment-decisions/Medxy AIen2026-10-04T04:33:14-07:00Reevaluating Sentinel Lymph Node Biopsy in Older Women with cT2N0 HR+/HER2- Breast Cancer: Limited Impact on Treatment Decisions https://news.medxy.ai/zh/80682-2/Medxy AIzh2026-10-04T04:32:37-07:00妇科肿瘤中的免疫疗法诱导性内分泌功能障碍：一项回顾性队列研究的临床见解 https://news.medxy.ai/ja/immune-therapy-endocrine-disorders/Medxy AIja2026-10-04T04:32:16-07:00婦人科腫瘍における免疫療法誘発性内分泌障害：後ろ向きコホート研究から得られた臨床的知見 https://news.medxy.ai/vi/80677-2/Medxy AIvi2026-10-04T04:31:50-07:00Rối loạn chức năng nội tiết do liệu pháp miễn dịch trong ung thư phụ khoa: Những hiểu biết lâm sàng từ nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/immunotherapy-induced-endocrine-dysfunction-in-gynecologic-oncology-clinical-insights-from-a-retrospective-cohort-study/Medxy AIen2026-10-04T04:31:28-07:00Immunotherapy-Induced Endocrine Dysfunction in Gynecologic Oncology: Clinical Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/serum-glp-1/Medxy AIzh2026-10-04T04:30:38-07:00血清 GLP-1：肥胖女性子宫内膜癌筛查的新型生物标志物 https://news.medxy.ai/ja/glp-1-biomarker/Medxy AIja2026-10-04T04:30:19-07:00肥満女性の子宮内膜がん検出における新規バイオマーカーとしての血清GLP-1 https://news.medxy.ai/vi/glp-1-biomarker-cancer/Medxy AIvi2026-10-04T04:30:00-07:00GLP-1 huyết thanh: dấu ấn sinh học mới đầy hứa hẹn trong phát hiện ung thư nội mạc tử cung ở phụ nữ béo phì https://news.medxy.ai/serum-glp-1-as-a-novel-biomarker-for-endometrial-cancer-detection-in-obese-women/Medxy AIen2026-10-04T04:29:41-07:00Serum GLP-1 as a Novel Biomarker for Endometrial Cancer Detection in Obese Women https://news.medxy.ai/zh/us-uterus-transplant-review/Medxy AIzh2026-10-04T04:29:02-07:00美国子宫移植10年回顾：手术安全、生殖里程碑与儿童发育结局 https://news.medxy.ai/ja/us-10-year-uterus-transplant/Medxy AIja2026-10-04T04:28:41-07:00米国の10年にわたる子宮移植：手術成績・生殖転帰・小児発達の検証 https://news.medxy.ai/vi/womb-transplant-success/Medxy AIvi2026-10-04T04:28:17-07:00Ghép tử cung sau 10 năm tại Hoa Kỳ: Thành công phẫu thuật, cột mốc sinh sản và kết cục phát triển của trẻ https://news.medxy.ai/ten-years-of-uterus-transplantation-in-the-us-surgical-success-reproductive-milestones-and-child-development-outcomes/Medxy AIen2026-10-04T04:27:57-07:00Ten Years of Uterus Transplantation in the US: Surgical Success, Reproductive Milestones, and Child Development Outcomes https://news.medxy.ai/zh/80651-2/Medxy AIzh2026-10-04T04:27:15-07:00产前检查数据与指标的更新以改善妊娠结局 https://news.medxy.ai/ja/pregnancy-outcomes-update/Medxy AIja2026-10-04T04:26:49-07:00妊娠転帰を高める妊婦健診データ・指標の刷新：包括的エビデンス統合 https://news.medxy.ai/vi/better-prenatal-care/Medxy AIvi2026-10-04T04:26:23-07:00Nâng cao kết cục thai kỳ bằng dữ liệu và chỉ số chăm sóc trước sinh tốt hơn: Tổng hợp bằng chứng toàn diện https://news.medxy.ai/improving-pregnancy-outcomes-through-enhanced-prenatal-care-data-and-metrics-a-comprehensive-evidence-synthesis/Medxy AIen2026-10-04T04:25:57-07:00Improving Pregnancy Outcomes Through Enhanced Prenatal Care Data and Metrics: A Comprehensive Evidence Synthesis https://news.medxy.ai/zh/liver-transplantation-immune-control/Medxy AIzh2026-10-04T04:24:58-07:00肝移植中的先天免疫炎症控制：HOPE 与 NMP 机器灌注的启示 https://news.medxy.ai/ja/liver-transplant-immunity/Medxy AIja2026-10-04T04:24:40-07:00肝移植における自然免疫応答をどう抑えるか：HOPEとNMP機械灌流が示す新知見 https://news.medxy.ai/vi/innate-immunity-liver-transplant/Medxy AIvi2026-10-04T04:24:15-07:00Giảm đáp ứng miễn dịch bẩm sinh trong ghép gan: Những hiểu biết từ HOPE và tưới máu máy NMP https://news.medxy.ai/mitigating-innate-immune-response-in-liver-transplantation-insights-from-hope-and-nmp-machine-perfusion/Medxy AIen2026-10-04T04:23:54-07:00Mitigating Innate Immune Response in Liver Transplantation: Insights from HOPE and NMP Machine Perfusion https://news.medxy.ai/zh/80629-2/Medxy AIzh2026-10-04T04:23:04-07:00医源性脑淀粉样血管病：长期病程与临床意义 https://news.medxy.ai/ja/80628-2/Medxy AIja2026-10-04T04:22:45-07:00医療介入に関連するアミロイド脳血管障害：長期経過と臨床的意義 https://news.medxy.ai/vi/amyloid-cerebral-disease/Medxy AIvi2026-10-04T04:22:24-07:00Bệnh não mạch amyloid do can thiệp y khoa: diễn tiến dài hạn và ý nghĩa lâm sàng https://news.medxy.ai/unraveling-iatrogenic-cerebral-amyloid-angiopathy-long-term-disease-progression-and-clinical-implications/Medxy AIen2026-10-04T04:22:04-07:00Unraveling Iatrogenic Cerebral Amyloid Angiopathy: Long-Term Disease Progression and Clinical Implications https://news.medxy.ai/zh/hearing-aid-cognition/Medxy AIzh2026-10-04T04:21:23-07:00助听器干预能否延缓轻度认知障碍老年人认知恶化？CHOICE随机临床试验给出新证据 https://news.medxy.ai/ja/hearing-aid-intervention/Medxy AIja2026-10-04T04:21:06-07:00軽度認知障害を有する高齢者における補聴器介入の評価：CHOICEランダム化臨床試験からの知見 https://news.medxy.ai/vi/hearing-aids-dementia/Medxy AIvi2026-10-04T04:20:47-07:00Máy trợ thính có giúp làm chậm sa sút trí tuệ ở người cao tuổi bị suy giảm nhận thức nhẹ? Bằng chứng từ thử nghiệm CHOICE https://news.medxy.ai/evaluating-hearing-aid-intervention-in-older-adults-with-mild-cognitive-impairment-insights-from-the-choice-randomized-clinical-trial/Medxy AIen2026-10-04T04:20:27-07:00Evaluating Hearing Aid Intervention in Older Adults with Mild Cognitive Impairment: Insights from the CHOICE Randomized Clinical Trial https://news.medxy.ai/zh/thyroid-nodules-followup/Medxy AIzh2026-10-04T04:19:41-07:00偶发性甲状腺结节：超声随访模式及临床意义 https://news.medxy.ai/ja/80608-2/Medxy AIja2026-10-04T04:19:23-07:00偶発的甲状腺結節：超音波による経過観察の様式と臨床的意義 https://news.medxy.ai/vi/thyroid-nodule-surveillance/Medxy AIvi2026-10-04T04:19:04-07:00Nhân tuyến giáp phát hiện tình cờ: Mô hình theo dõi bằng siêu âm và ý nghĩa lâm sàng https://news.medxy.ai/incidental-thyroid-nodules-ultrasound-follow-up-patterns-and-clinical-implications/Medxy AIen2026-10-04T04:18:44-07:00Incidental Thyroid Nodules: Ultrasound Follow-up Patterns and Clinical Implications https://news.medxy.ai/zh/80602-2/Medxy AIzh2026-10-04T04:18:06-07:00GAD-alum能长期推迟HLA-DR3-DQ2阳性1型糖尿病儿童发病 https://news.medxy.ai/ja/type-1-diabetes-prevention/Medxy AIja2026-10-04T04:17:46-07:001型糖尿病予防における精密医療：GAD-alum治療後のHLA-DR3-DQ2陽性児でみられたステージ3発症の長期遅延 https://news.medxy.ai/vi/precision-medicine-diabetes/Medxy AIvi2026-10-04T04:17:22-07:00Y học chính xác trong phòng ngừa đái tháo đường týp 1: GAD-alum giúp trì hoãn đáng kể khởi phát giai đoạn 3 ở trẻ HLA-DR3-DQ2 dương tính https://news.medxy.ai/precision-medicine-in-type-1-diabetes-prevention-long-term-delayed-onset-of-stage-3-diabetes-after-gad-alum-treatment-in-hla-dr3-dq2-positive-children/Medxy AIen2026-10-04T04:16:58-07:00Precision Medicine in Type 1 Diabetes Prevention: Long-Term Delayed Onset of Stage 3 Diabetes After GAD-Alum Treatment in HLA-DR3-DQ2-Positive Children https://news.medxy.ai/zh/glp1-safety-pregnancy/Medxy AIzh2026-10-04T04:15:57-07:00法国全国性研究解读：2 型糖尿病孕妇使用 GLP-1 受体激动剂及新型降糖药的安全性 https://news.medxy.ai/ja/80587-2/Medxy AIja2026-10-04T04:15:38-07:002型糖尿病の妊婦におけるGLP-1受容体作動薬および新規血糖降下薬の使用の安全性 https://news.medxy.ai/vi/glp-1-safety-pregnancy/Medxy AIvi2026-10-04T04:15:14-07:00Đánh giá tính an toàn của chất chủ vận thụ thể GLP-1 và các thuốc hạ glucose thế hệ mới ở thai phụ mắc đái tháo đường týp 2: Góc nhìn từ một nghiên cứu toàn quốc tại Pháp https://news.medxy.ai/evaluating-the-safety-of-glp-1-receptor-agonists-and-new-generation-glucose-lowering-agents-in-pregnant-women-with-type-2-diabetes-insights-from-a-french-nationwide-study/Medxy AIen2026-10-04T04:14:54-07:00Evaluating the Safety of GLP-1 Receptor Agonists and New-Generation Glucose-Lowering Agents in Pregnant Women with Type 2 Diabetes: Insights from a French Nationwide Study https://news.medxy.ai/zh/morning-saliva-critone/Medxy AIzh2026-10-04T04:14:11-07:00清晨唾液皮质酮可作为肾上腺功能不全筛查的可靠无创指标：来自英国真实世界队列的研究洞见 https://news.medxy.ai/ja/adrenal-insufficiency-screening/Medxy AIja2026-10-04T04:13:52-07:00早朝唾液コルチゾンによる副腎不全スクリーニング：英国リアルワールドコホートからの知見 https://news.medxy.ai/vi/80580-2/Medxy AIvi2026-10-04T04:13:27-07:00Nồng độ cortisol trong nước bọt vào sáng sớm có thể đóng vai trò là dấu ấn sàng lọc tình trạng suy tuyến thượng thận https://news.medxy.ai/morning-salivary-cortisone-as-a-reliable-non-invasive-screen-for-adrenal-insufficiency-insights-from-a-real-world-uk-cohort/Medxy AIen2026-10-04T04:13:09-07:00Morning Salivary Cortisone as a Reliable Non-Invasive Screen for Adrenal Insufficiency: Insights from a Real-World UK Cohort https://news.medxy.ai/zh/nocode-ai-thyroid-cancer/Medxy AIzh2026-10-04T04:12:25-07:00无代码AI助力甲状腺结节超声恶性分类：迈向更易获取、可重复的医学AI https://news.medxy.ai/ja/no-code-ai-thyroid-ultrasound/Medxy AIja2026-10-04T04:12:04-07:00ノーコードAIで切り拓く甲状腺結節超音波悪性判定：誰もが使える再現可能な医療AIへ https://news.medxy.ai/vi/ai-thyroid-cancer-classification/Medxy AIvi2026-10-04T04:11:42-07:00Khai thác AI No-Code trong phân loại ác tính nốt tuyến giáp bằng siêu âm: Bước tiến tới AI y khoa dễ tiếp cận và có thể tái lập https://news.medxy.ai/harnessing-no-code-ai-for-thyroid-nodule-ultrasound-malignancy-classification-a-leap-toward-accessible-and-reproducible-medical-ai/Medxy AIen2026-10-04T04:11:21-07:00Harnessing No-Code AI for Thyroid Nodule Ultrasound Malignancy Classification: A Leap Toward Accessible and Reproducible Medical AI https://news.medxy.ai/zh/metabolic-status-vitamin-d/Medxy AIzh2026-10-04T04:10:36-07:00代谢状态会影响糖尿病前期患者对活性维生素D的骨骼反应：DPVD试验的新发现 https://news.medxy.ai/ja/80555-2/Medxy AIja2026-10-04T04:10:17-07:00代謝状態は糖尿病予備群における活性型ビタミンDへの骨反応に影響を及ぼす https://news.medxy.ai/vi/80552-2/Medxy AIvi2026-10-04T04:09:57-07:00Tình trạng chuyển hóa có thể ảnh hưởng đến việc sử dụng vitamin D dạng hoạt động ở bệnh nhân tiền đái tháo đường https://news.medxy.ai/metabolic-status-influences-bone-response-to-active-vitamin-d-in-prediabetes-insights-from-the-dpvd-trial/Medxy AIen2026-10-04T04:09:38-07:00Metabolic Status Influences Bone Response to Active Vitamin D in Prediabetes: Insights from the DPVD Trial https://news.medxy.ai/zh/obesity-type-1-diabetes/Medxy AIzh2026-10-04T04:08:54-07:00超重与肥胖青少年1型糖尿病部分缓解识别面临挑战：来自SEARCH for Diabetes in Youth研究的启示 https://news.medxy.ai/ja/partial-remission-diabetes/Medxy AIja2026-10-04T04:08:34-07:00小児1型糖尿病における部分寛解判定でIDAA1cはどこまで有用か：SEARCH for Diabetes in Youth研究からの示唆 https://news.medxy.ai/vi/idaa1c-relapse-diabetes-type-1/Medxy AIvi2026-10-04T04:08:14-07:00IDAA1c để nhận diện lui bệnh một phần ở trẻ mắc đái tháo đường typ 1: thách thức từ nghiên cứu SEARCH for Diabetes in Youth https://news.medxy.ai/challenges-in-using-insulin-dose-adjusted-hba1c-to-identify-partial-remission-in-pediatric-type-1-diabetes-insights-from-the-search-for-diabetes-in-youth-study/Medxy AIen2026-10-04T04:07:56-07:00Challenges in Using Insulin Dose-Adjusted HbA1c to Identify Partial Remission in Pediatric Type 1 Diabetes: Insights from the SEARCH for Diabetes in Youth Study https://news.medxy.ai/zh/type-1-diabetes-sleep-apnea/Medxy AIzh2026-10-04T04:07:12-07:001型糖尿病老年患者阻塞性睡眠呼吸暂停风险升高、睡眠质量下降：来自 DCCT/EDIC 队列的启示 https://news.medxy.ai/ja/sleep-apnea-risk-elderly-diabetes/Medxy AIja2026-10-04T04:06:53-07:00高齢の1型糖尿病患者における閉塞性睡眠時無呼吸リスクと睡眠の質低下の増大：DCCT/EDICコホートからの知見 https://news.medxy.ai/vi/sleep-apnea-diabetes/Medxy AIvi2026-10-04T04:06:32-07:00Nguy cơ ngưng thở tắc nghẽn khi ngủ và chất lượng giấc ngủ kém tăng ở người lớn tuổi mắc đái tháo đường týp 1: Góc nhìn từ đoàn hệ DCCT/EDIC https://news.medxy.ai/increased-risk-of-obstructive-sleep-apnea-and-poor-sleep-quality-among-older-adults-with-type-1-diabetes-insights-from-the-dcct-edic-cohort/Medxy AIen2026-10-04T04:06:11-07:00Increased Risk of Obstructive Sleep Apnea and Poor Sleep Quality Among Older Adults With Type 1 Diabetes: Insights from the DCCT/EDIC Cohort https://news.medxy.ai/zh/petrelintide-obesity-management/Medxy AIzh2026-10-04T04:05:19-07:00Petrelintide：一种用于长期肥胖管理、前景可观的人胰淀素类似物 https://news.medxy.ai/ja/petrelintide-obesity-management-2/Medxy AIja2026-10-04T04:05:01-07:00Petrelintide、長期肥満管理に向けた有望なヒトアミリン類似体 https://news.medxy.ai/vi/petrelintide-amylin-obesity/Medxy AIvi2026-10-04T04:04:40-07:00Petrelintide: Chất tương tự amylin ở người đầy hứa hẹn cho kiểm soát béo phì lâu dài https://news.medxy.ai/petrelintide-a-promising-human-amylin-analogue-for-long-term-obesity-management/Medxy AIen2026-10-04T04:04:21-07:00Petrelintide: A Promising Human Amylin Analogue for Long-Term Obesity Management https://news.medxy.ai/zh/heartbit-transcriptomic-biomarker/Medxy AIzh2026-10-04T04:03:41-07:00HEARTBiT：一种用于心脏移植后早期急性细胞排斥反应检出的突破性转录组学生物标志物 https://news.medxy.ai/ja/heartbit-biomarker/Medxy AIja2026-10-04T04:03:21-07:00心臓移植後早期拒絶反応を捉える新規バイオマーカー「HEARTBiT」— トランスクリプトーム解析で切り開く低侵襲診断 https://news.medxy.ai/vi/heartbit-transcription-biomarker/Medxy AIvi2026-10-04T04:03:00-07:00HEARTBiT: Dấu ấn sinh học phiên mã học đột phá giúp phát hiện sớm thải ghép tế bào cấp tính sau ghép tim https://news.medxy.ai/heartbit-a-breakthrough-transcriptomic-biomarker-for-early-detection-of-acute-cellular-rejection-post-heart-transplantation/Medxy AIen2026-10-04T04:02:39-07:00HEARTBiT: A Breakthrough Transcriptomic Biomarker for Early Detection of Acute Cellular Rejection Post-Heart Transplantation https://news.medxy.ai/ja/cmr-cardiology-2026/Medxy AIja2026-10-04T04:01:57-07:00日常循環器診療にCMRをどう組み込むか――2026年EHJコンセンサスの要点 https://news.medxy.ai/vi/cmr-cardiology-practice/Medxy AIvi2026-10-04T04:01:19-07:00Đưa CMR vào thực hành tim mạch hằng ngày: các khuyến cáo then chốt từ đồng thuận EHJ 2026 https://news.medxy.ai/zh/cardiac-mri-guidelines/Medxy AIzh2026-10-04T04:00:45-07:00让心脏磁共振走进日常心内科：2026 年 EHJ 共识的关键建议 https://news.medxy.ai/bringing-cardiac-mri-into-everyday-cardiology-key-recommendations-from-the-2026-ehj-consensus/Medxy AIen2026-10-04T04:00:13-07:00Bringing Cardiac MRI into Everyday Cardiology: Key Recommendations from the 2026 EHJ Consensus https://news.medxy.ai/zh/smoc-1-heart-protection/Medxy AIzh2026-10-04T03:58:58-07:00SMOC-1：预防急性心肌梗死后心脏破裂的新型保护因子 https://news.medxy.ai/ja/80513-2/Medxy AIja2026-10-04T03:58:40-07:00SMOC-1：急性心筋梗塞後の心臓破裂を予防する新規保護因子 https://news.medxy.ai/vi/80512-2/Medxy AIvi2026-10-04T03:58:19-07:00SMOC-1: Một yếu tố bảo vệ mới chống lại tình trạng vỡ tim sau nhồi máu cơ tim cấp https://news.medxy.ai/secreted-modular-calcium-binding-protein-1-a-novel-protective-factor-to-prevent-cardiac-rupture-post-acute-myocardial-infarction/Medxy AIen2026-10-04T03:57:58-07:00Secreted Modular Calcium-Binding Protein 1: A Novel Protective Factor to Prevent Cardiac Rupture Post-Acute Myocardial Infarction https://news.medxy.ai/zh/tavr-stroke-rate/Medxy AIzh2026-10-04T03:57:15-07:00TAVR后卒中率为何“看起来更高”？医院卒中中心资质对质量评估的影响 https://news.medxy.ai/ja/tavr-stroke-rates/Medxy AIja2026-10-04T03:56:53-07:00TAVR後の脳卒中率報告は病院の脳卒中センター認定に左右される：質評価への示唆 https://news.medxy.ai/vi/stroke-center-quality/Medxy AIvi2026-10-04T03:56:27-07:00Trung tâm Đột quỵ của Bệnh viện Có Thể Làm Thay Đổi Tỷ Lệ Đột Quỵ Sau TAVR Được Báo Cáo: Hàm Ý Cho Đánh Giá Chất Lượng https://news.medxy.ai/hospital-stroke-center-designation-influences-reported-stroke-rates-after-tavr-implications-for-quality-assessment/Medxy AIen2026-10-04T03:56:05-07:00Hospital Stroke Center Designation Influences Reported Stroke Rates After TAVR: Implications for Quality Assessment https://news.medxy.ai/zh/aortic-aneurysm-mechanisms/Medxy AIzh2026-10-04T03:55:22-07:00揭开腹主动脉瘤的机制：表观遗传学与炎症、脂质代谢的关联 https://news.medxy.ai/ja/abdominal-aortic-aneurysm/Medxy AIja2026-10-04T03:55:02-07:00腹部大動脈瘤の病態を解く：炎症と脂質代謝をつなぐエピジェネティクス https://news.medxy.ai/vi/80502-2/Medxy AIvi2026-10-04T03:54:39-07:00Giải mã cơ chế bệnh phình động mạch chủ bụng: Sự tương tác giữa di truyền ngoại gen, tình trạng viêm và chuyển hóa lipid https://news.medxy.ai/unraveling-abdominal-aortic-aneurysm-epigenetic-links-to-inflammation-and-lipid-metabolism/Medxy AIen2026-10-04T03:54:17-07:00Unraveling Abdominal Aortic Aneurysm: Epigenetic Links to Inflammation and Lipid Metabolism https://news.medxy.ai/zh/80491-2/Medxy AIzh2026-10-04T03:23:42-07:00再灌注后的微血管功能障碍可预测进展性脑梗死及不良预后 https://news.medxy.ai/ja/80490-2/Medxy AIja2026-10-04T03:23:13-07:00再灌流後の微小循環障害は、脳梗塞の進行および予後不良を予測する可能性がある https://news.medxy.ai/vi/microvascular-disorder-predicts-stroke/Medxy AIvi2026-10-04T03:22:41-07:00Rối loạn vi mạch sau tái tưới máu có thể dự báo nhồi máu đột quỵ tiến triển và tiên lượng xấu https://news.medxy.ai/microvascular-dysfunction-after-reperfusion-predicts-stroke-infarct-expansion-and-poor-outcomes/Medxy AIen2026-10-04T03:22:11-07:00Microvascular Dysfunction After Reperfusion Predicts Stroke Infarct Expansion and Poor Outcomes https://news.medxy.ai/zh/youth-mental-health-service-use/Medxy AIzh2026-10-04T03:21:24-07:00远离家乡接受精神科住院治疗后，青年医疗服务利用的变化：来自英格兰及相关研究证据的综合综述 https://news.medxy.ai/ja/psychiatric-hospitalization-impact/Medxy AIja2026-10-04T03:20:57-07:00遠隔地での精神科入院後、若年者の医療利用はどう変わるのか：イングランドのエビデンスと関連研究を総覧する https://news.medxy.ai/vi/mental-health-service-use/Medxy AIvi2026-10-04T03:20:23-07:00Sử dụng dịch vụ y tế ở người trẻ sau khi nhập viện sức khỏe tâm thần xa nhà: Tổng quan toàn diện bằng chứng từ Anh và các nghiên cứu liên quan https://news.medxy.ai/health-service-use-in-young-people-following-mental-health-admission-far-from-home-a-comprehensive-review-of-evidence-from-england-and-related-studies/Medxy AIen2026-10-04T03:19:52-07:00Health Service Use in Young People Following Mental Health Admission Far from Home: A Comprehensive Review of Evidence from England and Related Studies https://news.medxy.ai/zh/pertussis-antibiotic-evidence/Medxy AIzh2026-10-03T08:08:51-07:00百日咳婴儿抗菌治疗新证据：意大利医院真实世界研究显示克拉霉素优于阿奇霉素 https://news.medxy.ai/ja/79982-2/Medxy AIja2026-10-03T08:08:33-07:00百日咳の乳児において、クラリスロマイシンはアジスロマイシンより優れている https://news.medxy.ai/vi/79978-2/Medxy AIvi2026-10-03T08:08:09-07:00Các nghiên cứu thực tế cho thấy clarithromycin vượt trội hơn azithromycin ở trẻ nhũ nhi mắc bệnh ho gà https://news.medxy.ai/clarithromycin-vs-azithromycin-for-infant-pertussis-real-world-outcomes-from-italian-hospitals/Medxy AIen2026-10-03T08:07:49-07:00Clarithromycin vs Azithromycin for Infant Pertussis: Real-World Outcomes from Italian Hospitals https://news.medxy.ai/zh/pcv-vaccine-followup/Medxy AIzh2026-10-03T08:07:04-07:00南非肺炎球菌结合疫苗加强免疫后最长追踪至5岁：PCV10与PCV13婴儿1+1及2+1程序的随机对照试验延长随访 https://news.medxy.ai/ja/pneumococcal-vaccine-study/Medxy AIja2026-10-03T08:06:39-07:00南アフリカにおける10価・13価肺炎球菌結合型ワクチンの乳児初回接種後、5歳までの免疫原性：ブースター追加を伴う延長RCT追跡 https://news.medxy.ai/vi/pcv13-immunity-children/Medxy AIvi2026-10-03T08:06:16-07:00Miễn dịch của PCV13 kéo dài đến 5 tuổi sau lịch tiêm 1 hoặc 2 liều khởi đầu ở trẻ nhỏ kèm liều nhắc tại Nam Phi: theo dõi mở rộng của thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/immunogenicity-up-to-age-5-following-single-or-two-dose-infant-primary-series-of-10-valent-and-13-valent-pneumococcal-conjugate-vaccine-with-booster-in-south-africa-extended-rct-follow-up/Medxy AIen2026-10-03T08:05:54-07:00Immunogenicity up to Age 5 Following Single- or Two-Dose Infant Primary Series of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine with Booster in South Africa: Extended RCT Follow-Up https://news.medxy.ai/health-service-utilization-among-young-people-following-out-of-area-mental-health-admissions-evidence-from-a-retrospective-cohort-study-in-england/Medxy AIen2026-10-03T08:00:12-07:00Health Service Utilization Among Young People Following Out-of-Area Mental Health Admissions: Evidence from a Retrospective Cohort Study in England https://news.medxy.ai/zh/extremely-preterm-birth/Medxy AIzh2026-10-03T07:59:21-07:00超早产与极低出生体重人群成年福祉的儿童期预测因素：一项34年队列研究的启示 https://news.medxy.ai/ja/early-birth-wellbeing/Medxy AIja2026-10-03T07:59:03-07:00超早産・超低出生体重で生まれた人の成人ウェルビーイングを左右する小児期予測因子：34年コホート研究からの知見 https://news.medxy.ai/vi/childhood-predictors-health/Medxy AIvi2026-10-03T07:58:41-07:00Những yếu tố dự báo từ thời thơ ấu đối với sức khỏe và thích nghi tốt ở tuổi trưởng thành ở người sinh cực non và/hoặc có cân nặng lúc sinh rất thấp: phát hiện từ nghiên cứu đoàn hệ 34 năm https://news.medxy.ai/childhood-predictors-of-adult-well-being-in-very-preterm-and-very-low-birth-weight-individuals-insights-from-a-34-year-cohort-study/Medxy AIen2026-10-03T07:58:19-07:00Childhood Predictors of Adult Well-Being in Very Preterm and Very Low Birth Weight Individuals: Insights From a 34-Year Cohort Study https://news.medxy.ai/zh/rsv-infant-protection/Medxy AIzh2026-10-02T07:57:33-07:00高风险婴儿重症 RSV 的长效防护：两季随机试验揭示克雷索维单抗潜力 https://news.medxy.ai/ja/high-risk-infant-rsv-prevention/Medxy AIja2026-10-02T07:57:12-07:00高リスク乳児の重症RSVを長期に防ぐclesrovimab：2シーズン無作為化試験からの知見 https://news.medxy.ai/vi/clesrovimab-rsv-prevention-4/Medxy AIvi2026-10-02T07:56:49-07:00Clesrovimab: hy vọng mới trong phòng ngừa RSV nặng kéo dài ở trẻ sơ sinh nguy cơ cao https://news.medxy.ai/clesrovimab-for-prolonged-protection-against-severe-rsv-in-high-risk-infants-insights-from-a-two-season-randomized-trial/Medxy AIen2026-10-02T07:56:29-07:00Clesrovimab for Prolonged Protection Against Severe RSV in High-Risk Infants: Insights From a Two-Season Randomized Trial https://news.medxy.ai/zh/38-percent-silver-ammonium-fluoride/Medxy AIzh2026-10-02T07:55:46-07:0038%银氨氟化物：重度幼儿期龋的非侵入性治疗新突破 https://news.medxy.ai/ja/silver-diamine-fluoride/Medxy AIja2026-10-02T07:55:26-07:0038％silver diamine fluorideが切り開く新たな小児う蝕治療――米国の重度幼児う蝕に対する非侵襲的ブレークスルー https://news.medxy.ai/vi/silver-diamine-fluoride-2/Medxy AIvi2026-10-02T07:55:01-07:00Bạc diamine fluoride: Liệu pháp không xâm lấn đột phá cho sâu răng sớm ở trẻ em nặng tại Hoa Kỳ https://news.medxy.ai/silver-diamine-fluoride-a-breakthrough-noninvasive-therapy-for-severe-early-childhood-caries-in-us-children/Medxy AIen2026-10-02T07:54:37-07:00Silver Diamine Fluoride: A Breakthrough Noninvasive Therapy for Severe Early Childhood Caries in US Children https://news.medxy.ai/zh/pediatric-tbi-ct-use/Medxy AIzh2026-10-02T07:53:59-07:00儿童轻型创伤性脑损伤头部CT使用率居高不下：不同医院类型差异及其对临床实践的启示 https://news.medxy.ai/ja/79927-2/Medxy AIja2026-10-02T07:53:38-07:00小児の軽症外傷性脳損傷における頭部CT撮影率の高止まり https://news.medxy.ai/vi/79926-2/Medxy AIvi2026-10-02T07:53:11-07:00Tỷ lệ sử dụng chụp CT đối với chấn thương sọ não nhẹ ở trẻ em vẫn duy trì ở mức cao https://news.medxy.ai/persistent-high-rates-of-head-ct-in-pediatric-mild-traumatic-brain-injury-variability-among-hospital-types-and-implications-for-practice/Medxy AIen2026-10-02T07:52:48-07:00Persistent High Rates of Head CT in Pediatric Mild Traumatic Brain Injury: Variability Among Hospital Types and Implications for Practice https://news.medxy.ai/zh/type-1-diabetes-intervention/Medxy AIzh2026-10-02T07:52:05-07:00儿童1型糖尿病的行为干预：以家庭为中心的多组分策略优化血糖控制 https://news.medxy.ai/ja/pediatric-type1-diabetes/Medxy AIja2026-10-02T07:51:42-07:00小児1型糖尿病における行動介入：家族中心の多要素戦略で血糖管理を最適化する https://news.medxy.ai/vi/behavioral-intervention-type-1-diabetes/Medxy AIvi2026-10-02T07:51:19-07:00Can thiệp hành vi trong đái tháo đường type 1 ở trẻ em: tối ưu kiểm soát đường huyết bằng chiến lược đa thành phần, lấy gia đình làm trung tâm https://news.medxy.ai/behavioral-interventions-in-pediatric-type-1-diabetes-optimizing-glycemic-control-through-family-centered-multicomponent-strategies/Medxy AIen2026-10-02T07:50:54-07:00Behavioral Interventions in Pediatric Type 1 Diabetes: Optimizing Glycemic Control Through Family-Centered, Multicomponent Strategies https://news.medxy.ai/zh/79910-2/Medxy AIzh2026-10-02T07:50:10-07:00加强对拉美裔家庭婴幼儿读写能力的支持：一项验证短信与社区资源推介有效性的三组随机对照试验（RCT） https://news.medxy.ai/ja/latin-family-literacy/Medxy AIja2026-10-02T07:49:49-07:00ラテン系家族の乳幼児リテラシー支援を強化：テキストメッセージと地域資源紹介の有効性を検証した3群RCT https://news.medxy.ai/vi/promoting-childrens-reading/Medxy AIvi2026-10-02T07:49:20-07:00Tăng cường thúc đẩy đọc sách cho trẻ em trong các gia đình Latino: hiệu quả của nhắn tin văn bản và giới thiệu nguồn lực trong thử nghiệm ngẫu nhiên có đối chứng 3 nhánh https://news.medxy.ai/enhancing-pediatric-literacy-promotion-for-latino-families-efficacy-of-text-messaging-and-resource-referrals-in-a-3-arm-randomized-controlled-trial/Medxy AIen2026-10-02T07:48:55-07:00Enhancing Pediatric Literacy Promotion for Latino Families: Efficacy of Text Messaging and Resource Referrals in a 3-Arm Randomized Controlled Trial https://news.medxy.ai/zh/mri-ultrasound-arthritis/Medxy AIzh2026-10-02T07:48:06-07:00MRI 与超声可预测 anti-CCP 阳性无临床滑膜炎患者进展为炎性关节炎 https://news.medxy.ai/ja/inflammatory-arthritis-risk/Medxy AIja2026-10-02T07:47:42-07:00MRIと超音波で見抜く炎症性関節炎リスク：anti-CCP陽性・無症候性滑膜炎患者の予測因子 https://news.medxy.ai/vi/anti-ccp-arthritis-markers/Medxy AIvi2026-10-02T07:47:19-07:00Dấu ấn hình ảnh nào dự báo viêm khớp viêm ở người anti-CCP dương tính chưa có viêm hoạt dịch lâm sàng? https://news.medxy.ai/imaging-biomarkers-predicting-inflammatory-arthritis-in-anti-ccp-positive-patients-without-clinical-synovitis/Medxy AIen2026-10-02T07:46:56-07:00Imaging Biomarkers Predicting Inflammatory Arthritis in Anti-CCP Positive Patients Without Clinical Synovitis https://news.medxy.ai/zh/anca-vasculitis-relapse-risk/Medxy AIzh2026-10-02T07:46:16-07:00预测ANCA相关性血管炎两年复发风险：来自 PEXIVAS 试验的启示 https://news.medxy.ai/ja/anca-vasculitis-relapse-risk-3/Medxy AIja2026-10-02T07:45:54-07:00ANCA関連血管炎の2年再燃リスクを予測：PEXIVAS試験から見えた知見 https://news.medxy.ai/vi/anca-vasculitis-relapse-risk-2/Medxy AIvi2026-10-02T07:45:26-07:00Dự đoán nguy cơ tái phát trong 2 năm ở viêm mạch liên quan đến ANCA: Gợi ý từ thử nghiệm PEXIVAS https://news.medxy.ai/predicting-two-year-relapse-risk-in-anca-associated-vasculitis-insights-from-the-pexivas-trial/Medxy AIen2026-10-02T07:45:03-07:00Predicting Two-Year Relapse Risk in ANCA-Associated Vasculitis: Insights from the PEXIVAS Trial https://news.medxy.ai/zh/canakinumab-biomarkers/Medxy AIzh2026-10-02T07:44:24-07:00预测 canakinumab 减量成功的分子标志物：系统性幼年特发性关节炎的新线索 https://news.medxy.ai/ja/79884-2/Medxy AIja2026-10-02T07:44:03-07:00カナキヌマブ減量成功を予測する分子バイオマーカー https://news.medxy.ai/vi/canakinumab-dose-reduction/Medxy AIvi2026-10-02T07:43:39-07:00Các dấu ấn phân tử dự đoán khả năng giảm liều canakinumab thành công trong viêm khớp tự phát thiếu niên thể hệ thống https://news.medxy.ai/molecular-biomarkers-predicting-canakinumab-tapering-success-in-systemic-juvenile-idiopathic-arthritis/Medxy AIen2026-10-02T07:43:16-07:00Molecular Biomarkers Predicting Canakinumab Tapering Success in Systemic Juvenile Idiopathic Arthritis https://news.medxy.ai/zh/native-vs-transplant-bk-virus/Medxy AIzh2026-10-02T07:42:36-07:00原生肾与移植肾BK多瘤病毒肾病的比较：一项匹配队列研究中的临床与病理洞见 https://news.medxy.ai/ja/bk-polyomavirus-nephropathy/Medxy AIja2026-10-02T07:42:13-07:00自己腎と移植腎のBKポリオーマウイルス腎症を比較する：マッチドコホート研究からみた臨床・病理学的考察 https://news.medxy.ai/vi/79878-2/Medxy AIvi2026-10-02T07:41:49-07:00So sánh bệnh thận do virus BK Polyoma ở thận tự thân và thận ghép https://news.medxy.ai/comparative-insights-into-native-and-allograft-bk-polyomavirus-nephropathy-clinical-and-pathological-perspectives-from-a-matched-cohort-study/Medxy AIen2026-10-02T07:41:25-07:00Comparative Insights into Native and Allograft BK Polyomavirus Nephropathy: Clinical and Pathological Perspectives from a Matched Cohort Study https://news.medxy.ai/zh/optimize-kidney-transplant/Medxy AIzh2026-10-02T07:40:36-07:00优化肾移植结局：来自全国性双肾与单肾移植比较研究的启示 https://news.medxy.ai/ja/79866-2/Medxy AIja2026-10-02T07:40:14-07:00腎移植成績の最適化：両腎移植と単腎移植を比較した全国規模の研究からの示唆 https://news.medxy.ai/vi/kidney-transplant-optimization/Medxy AIvi2026-10-02T07:39:38-07:00Tối ưu hóa kết quả ghép thận: Góc nhìn từ một nghiên cứu quốc gia về ghép thận đôi so với ghép thận đơn https://news.medxy.ai/optimizing-kidney-transplant-outcomes-insights-from-a-national-study-on-dual-versus-single-kidney-transplantation/Medxy AIen2026-10-02T07:39:15-07:00Optimizing Kidney Transplant Outcomes: Insights from a National Study on Dual Versus Single Kidney Transplantation https://news.medxy.ai/zh/spain-organ-donation-trends/Medxy AIzh2026-10-02T07:38:23-07:00西班牙脑死亡器官捐献格局如何变化：神经重症医学与器官捐献趋势的全国概览 https://news.medxy.ai/ja/brain-death-organ-donation-spain/Medxy AIja2026-10-02T07:38:01-07:00スペインにおける脳死下臓器提供の変化：神経集中治療と臓器提供動向の全国的概観 https://news.medxy.ai/vi/spain-organ-donation/Medxy AIvi2026-10-02T07:37:36-07:00Tây Ban Nha trước sự dịch chuyển của hiến tạng sau chết não: Tổng quan quốc gia về hồi sức thần kinh và xu hướng hiến tạng https://news.medxy.ai/changing-brain-death-donation-dynamics-in-spain-a-national-overview-of-neurocritical-care-and-organ-donation-trends/Medxy AIen2026-10-02T07:37:14-07:00Changing Brain Death Donation Dynamics in Spain: A National Overview of Neurocritical Care and Organ Donation Trends https://news.medxy.ai/zh/medicaid-liver-transplant/Medxy AIzh2026-10-02T07:36:25-07:00Medicaid 扩大覆盖如何改善成人肝移植结局：长达十年的研究分析 https://news.medxy.ai/ja/medicaid-liver-transplant-2/Medxy AIja2026-10-02T07:36:08-07:00Medicaid拡大が成人肝移植転帰に与える影響：10年間の解析 https://news.medxy.ai/vi/medicaid-expansion-liver-transplant/Medxy AIvi2026-10-02T07:35:49-07:00Mở rộng Medicaid tác động thế nào đến kết cục ghép gan ở người lớn? Phân tích kéo dài 10 năm https://news.medxy.ai/impact-of-medicaid-expansion-on-adult-liver-transplant-outcomes-a-decade-long-analysis/Medxy AIen2026-10-02T07:35:29-07:00Impact of Medicaid Expansion on Adult Liver Transplant Outcomes: A Decade-Long Analysis https://news.medxy.ai/zh/lung-function-transplant/Medxy AIzh2026-10-02T07:34:43-07:00肝移植受者肺功能受损与呼吸困难：全国匹配队列研究带来的启示 https://news.medxy.ai/ja/lung-function-decline/Medxy AIja2026-10-02T07:34:23-07:00肝移植レシピエントにおける肺機能低下と呼吸困難：全国マッチドコホート研究からの示唆 https://news.medxy.ai/vi/lung-function-decline-2/Medxy AIvi2026-10-02T07:34:03-07:00Suy giảm chức năng phổi và khó thở ở người nhận ghép gan: bằng chứng từ một nghiên cứu đoàn hệ ghép cặp toàn quốc https://news.medxy.ai/impaired-pulmonary-function-and-dyspnea-in-liver-transplant-recipients-insights-from-a-nationwide-matched-cohort-study/Medxy AIen2026-10-02T07:33:43-07:00Impaired Pulmonary Function and Dyspnea in Liver Transplant Recipients: Insights from a Nationwide Matched Cohort Study https://news.medxy.ai/zh/liver-transplantation-advances/Medxy AIzh2026-10-02T07:32:59-07:00循环死亡后捐献肝移植新进展：常温机器灌注与区域灌注结局比较 https://news.medxy.ai/ja/liver-transplantation-comparison/Medxy AIja2026-10-02T07:32:35-07:00循環停止後臓器提供肝移植を前進させる：常温機械灌流と区域灌流の成績比較 https://news.medxy.ai/vi/liver-transplantation-comparison-2/Medxy AIvi2026-10-02T07:32:11-07:00Nâng tầm ghép gan từ người hiến sau ngừng tuần hoàn: so sánh kết cục tưới máu máy ở thân nhiệt bình thường và tưới máu vùng https://news.medxy.ai/advancing-donation-after-circulatory-death-liver-transplants-comparing-normothermic-machine-and-regional-perfusion-outcomes/Medxy AIen2026-10-02T07:31:48-07:00Advancing Donation After Circulatory Death Liver Transplants: Comparing Normothermic Machine and Regional Perfusion Outcomes https://news.medxy.ai/zh/dupilumab-eczema-kids/Medxy AIzh2026-10-02T07:31:04-07:00dupilumab治疗儿童中重度特应性皮炎：荷兰3年队列研究揭示长期疗效与安全性 https://news.medxy.ai/ja/dupilumab-child-eczema/Medxy AIja2026-10-02T07:30:42-07:00中等症から重症の小児アトピー性皮膚炎におけるDupilumabの長期有効性と安全性：オランダ3年間コホート研究からの知見 https://news.medxy.ai/vi/dupilumab-long-term-safety/Medxy AIvi2026-10-02T07:30:15-07:00Dupilumab duy trì hiệu quả và độ an toàn lâu dài ở trẻ em mắc viêm da cơ địa mức độ trung bình đến nặng: Kết quả từ nghiên cứu đoàn hệ 3 năm tại Hà Lan https://news.medxy.ai/sustained-efficacy-and-safety-of-dupilumab-in-children-with-moderate-to-severe-atopic-dermatitis-insights-from-a-3-year-dutch-cohort-study/Medxy AIen2026-10-02T07:29:55-07:00Sustained Efficacy and Safety of Dupilumab in Children with Moderate to Severe Atopic Dermatitis: Insights from a 3-Year Dutch Cohort Study https://news.medxy.ai/zh/arotitinib-cream-study/Medxy AIzh2026-10-02T07:29:01-07:001.5%芦可替尼乳膏治疗皮肤型扁平苔藓的疗效与安全性：随机临床试验综述 https://news.medxy.ai/ja/lansopitinib-skin-trial/Medxy AIja2026-10-02T07:28:41-07:00皮膚扁平苔癬に対するランソリチニブ外用クリームの有効性と安全性：ランダム化臨床試験レビュー https://news.medxy.ai/vi/ruxolitinib-cream-lichen-planus/Medxy AIvi2026-10-02T07:28:18-07:00Ruxolitinib cream trong lichen phẳng da: Hiệu quả, độ an toàn và ý nghĩa từ một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/efficacy-and-safety-of-ruxolitinib-cream-in-patients-with-cutaneous-lichen-planus-a-randomized-clinical-trial-review/Medxy AIen2026-10-02T07:27:57-07:00Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial Review https://news.medxy.ai/high-dose-oral-vitamin-d-for-management-of-chemotherapy-and-radiation-induced-skin-toxicity-a-multicenter-case-series/Medxy AIen2026-10-02T07:27:10-07:00High-Dose Oral Vitamin D for Management of Chemotherapy- and Radiation-Induced Skin Toxicity: A Multicenter Case Series https://news.medxy.ai/zh/rituximab-pemphigus-prediction/Medxy AIzh2026-10-02T07:26:27-07:00利妥昔单抗联合糖皮质激素治疗天疱疮患者短期结局的预测：来自中国多中心队列的启示 https://news.medxy.ai/ja/pemphigus-treatment-prediction/Medxy AIja2026-10-02T07:26:06-07:00リツキシマブ＋グルココルチコイド治療中の天疱瘡患者における短期転帰予測：中国多施設コホートからの知見 https://news.medxy.ai/vi/79791-2/Medxy AIvi2026-10-02T07:25:44-07:00Kết quả ngắn hạn của việc phối hợp rituximab và glucocorticoid ở bệnh nhân mắc bệnh pemphigus https://news.medxy.ai/predicting-short-term-outcomes-in-pemphigus-patients-treated-with-rituximab-and-glucocorticoids-insights-from-a-multicenter-chinese-cohort/Medxy AIen2026-10-02T07:25:26-07:00Predicting Short-Term Outcomes in Pemphigus Patients Treated with Rituximab and Glucocorticoids: Insights from a Multicenter Chinese Cohort https://news.medxy.ai/zh/dupilumab-atopic-dermatitis/Medxy AIzh2026-10-02T07:24:45-07:00儿童中重度特应性皮炎系统治疗新证据：PEDISTAD 登记研究显示 dupilumab 跨肤色疗效更佳 https://news.medxy.ai/ja/atopic-dermatitis-treatment/Medxy AIja2026-10-02T07:24:24-07:00PEDISTADレジストリが示した小児中等症から重症アトピー性皮膚炎に対する全身治療：皮膚色別の比較成績 https://news.medxy.ai/vi/atopic-dermatitis-treatment-2/Medxy AIvi2026-10-02T07:24:01-07:00Điều trị toàn thân viêm da cơ địa mức độ vừa đến nặng ở trẻ em: so sánh kết quả theo màu da từ cơ sở đăng ký PEDISTAD https://news.medxy.ai/systemic-therapies-for-pediatric-moderate-to-severe-atopic-dermatitis-comparative-outcomes-across-skin-colors-from-the-pedistad-registry/Medxy AIen2026-10-02T07:23:40-07:00Systemic Therapies for Pediatric Moderate-to-Severe Atopic Dermatitis: Comparative Outcomes Across Skin Colors from the PEDISTAD Registry https://news.medxy.ai/zh/plaque-psoriasis-flare/Medxy AIzh2026-10-02T07:22:58-07:00停用生物制剂后斑块型银屑病出现独特脓疱性发作：临床特征与危险因素 https://news.medxy.ai/ja/psoriasis-flare-after-treatment/Medxy AIja2026-10-02T07:22:38-07:00生物学的製剤中止後にみられる尋常性乾癬の特異的膿疱性増悪：臨床像と危険因子 https://news.medxy.ai/vi/psoriasis-pustular-flare/Medxy AIvi2026-10-02T07:22:16-07:00Bùng phát vảy nến mụn mủ đặc thù sau khi ngừng thuốc sinh học ở vảy nến mảng bám: đặc điểm lâm sàng và yếu tố nguy cơ https://news.medxy.ai/distinct-pustular-psoriasis-flares-after-biologic-withdrawal-in-plaque-psoriasis-clinical-features-and-risk-factors/Medxy AIen2026-10-02T07:21:53-07:00Distinct Pustular Psoriasis Flares After Biologic Withdrawal in Plaque Psoriasis: Clinical Features and Risk Factors https://news.medxy.ai/zh/breast-reconstruction-outcomes-2/Medxy AIzh2026-10-02T07:21:11-07:00两期乳房重建中聚二氧环己酮合成网片的短期结局：单中心比较研究的启示 https://news.medxy.ai/ja/polydioxanone-mesh-results/Medxy AIja2026-10-02T07:20:52-07:002期的乳房再建におけるポリジオキサノン合成メッシュの短期成績：単施設比較研究からの知見 https://news.medxy.ai/vi/polydioxanone-breast-reconstruction/Medxy AIvi2026-10-02T07:20:30-07:00Kết quả ngắn hạn của lưới tổng hợp polydioxanone trong tái tạo vú hai giai đoạn: Bằng chứng từ một nghiên cứu so sánh đơn trung tâm https://news.medxy.ai/short-term-outcomes-of-polydioxanone-synthetic-mesh-in-two-stage-breast-reconstruction-insights-from-a-single-center-comparative-study/Medxy AIen2026-10-02T07:20:12-07:00Short-Term Outcomes of Polydioxanone Synthetic Mesh in Two-Stage Breast Reconstruction: Insights from a Single-Center Comparative Study https://news.medxy.ai/zh/five-factor-weakness-index/Medxy AIzh2026-10-02T07:19:34-07:00五因素改良衰弱指数能否预测乳房缩小成形术后伤口愈合并发症？高龄或许更关键 https://news.medxy.ai/ja/breast-reduction-healing/Medxy AIja2026-10-02T07:19:11-07:00乳房縮小術後の創傷治癒合併症は予測できるか――5因子修正版フレイル指標の実力を検証 https://news.medxy.ai/vi/79748-2/Medxy AIvi2026-10-02T07:18:47-07:00Liệu có thể dự đoán các biến chứng lành vết thương sau phẫu thuật thu nhỏ vú? https://news.medxy.ai/assessing-the-predictive-value-of-the-5-factor-modified-frailty-index-for-wound-healing-complications-in-reduction-mammoplasty/Medxy AIen2026-10-02T07:18:25-07:00Assessing the Predictive Value of the 5-Factor Modified Frailty Index for Wound-Healing Complications in Reduction Mammoplasty https://news.medxy.ai/zh/adm-reconstruction-timing/Medxy AIzh2026-10-02T07:17:44-07:00前胸壁两期乳房重建中ADM植入时机如何优化：在包膜挛缩与并发症之间寻找平衡 https://news.medxy.ai/ja/adm-timing-optimization/Medxy AIja2026-10-02T07:17:25-07:00前胸壁2段階乳房再建におけるADM留置時期の最適化：被膜拘縮と合併症の両立 https://news.medxy.ai/vi/optimal-adm-timing/Medxy AIvi2026-10-02T07:17:05-07:00Tối ưu thời điểm đặt Acellular Dermal Matrix trong tái tạo vú trước cơ hai thì: Cân bằng giữa co thắt bao xơ và biến chứng https://news.medxy.ai/optimizing-acellular-dermal-matrix-timing-in-2-stage-prepectoral-breast-reconstruction-balancing-capsular-contracture-and-complications/Medxy AIen2026-10-02T07:16:43-07:00Optimizing Acellular Dermal Matrix Timing in 2-Stage Prepectoral Breast Reconstruction: Balancing Capsular Contracture and Complications https://news.medxy.ai/zh/optimize-dermal-matrix-size/Medxy AIzh2026-10-02T07:16:03-07:00优化无细胞真皮基质尺寸：降低胸肌前乳房重建包膜挛缩风险 https://news.medxy.ai/ja/adm-size-optimization/Medxy AIja2026-10-02T07:15:42-07:00前胸筋下乳房再建における被膜拘縮を抑えるADMサイズの最適化 https://news.medxy.ai/vi/optimize-dermal-matrix/Medxy AIvi2026-10-02T07:15:18-07:00Tối ưu hóa kích thước acellular dermal matrix để giảm co thắt bao xơ trong tái tạo vú trước cơ ngực https://news.medxy.ai/optimizing-acellular-dermal-matrix-size-to-minimize-capsular-contracture-in-prepectoral-breast-reconstruction/Medxy AIen2026-10-02T07:14:57-07:00Optimizing Acellular Dermal Matrix Size to Minimize Capsular Contracture in Prepectoral Breast Reconstruction https://news.medxy.ai/zh/migraine-surgery-timing/Medxy AIzh2026-10-02T07:14:17-07:00偏头痛触发点手术越早做，术后头痛改善越明显：来自台湾队列研究的启示 https://news.medxy.ai/ja/migraine-surgery-timing-2/Medxy AIja2026-10-02T07:13:55-07:00片頭痛手術は早いほど良い？ 台湾コホート研究が示す術後頭痛改善の鍵 https://news.medxy.ai/vi/79731-2/Medxy AIvi2026-10-02T07:13:34-07:00Phẫu thuật điều trị đau nửa đầu: Càng sớm càng tốt? Nghiên cứu đoàn hệ tại Đài Loan chỉ ra chìa khóa giúp cải thiện tình trạng đau đầu sau phẫu thuật https://news.medxy.ai/earlier-intervention-with-migraine-trigger-site-surgery-linked-to-improved-postoperative-headache-outcomes-insights-from-a-taiwanese-cohort-study/Medxy AIen2026-10-02T07:13:14-07:00Earlier Intervention with Migraine Trigger-Site Surgery Linked to Improved Postoperative Headache Outcomes: Insights from a Taiwanese Cohort Study